Response to Letter to the Editor re: 'Serious adverse events and deaths in PCSK9 inhibitor trials reported on ClinicalTrials.gov: a systematic review': 'serious adverse events and deaths in PCSK9 inhibitor trials reported on ClinicalTrials.gov: a systematic review'
| Autor: | van Bruggen, F H, Nijhuis, G B J, Zuidema, S U, Luijendijk, H J |
|---|---|
| Přispěvatelé: | Life Course Epidemiology (LCE) |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Expert Review of Clinical Pharmacology, 14(2). TAYLOR & FRANCIS LTD |
| ISSN: | 1751-2433 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|